Dr. Sheean joined our faculty in February 1998. He serves as Director of the Neuromuscular Division and has established a thriving practice that incorporates teaching and clinical research activities.
He is a highly talented clinician with expertise in the use of botox to treat spasticity and movement disorders. Dr. Sheean maintains a demanding schedule of clinical activities, including several weekly clinics: five EMG clinic sessions, one neuromuscular clinic, one ALS clinic, one botulinum toxin injection clinic, and one botulinum toxin review and assessment clinic. Additional sessions are held on an as-needed basis.
He treats patients with a variety of neuromuscular conditions, including myasthenia gravis and peripheral neuropathy. Clinics are conducted at the UCSD Medical Center in Hillcrest and at the Perlman Ambulatory Care Center in La Jolla. In July 2003, Dr. Sheean was named Director of the Neurology Outpatient Clinic at Perlman. In July 2004, he helped to establish the ALS Center at the UCSD Medical Center in Hillcrest and served as Co-Director for the first two years of operations.
As Director of the Neuromuscular Fellowship Program, Dr. Sheean is responsible for the selection and training of fellows. All of his clinics incorporate teaching for EMG Fellows and neurology residents. He provides training in EMG and nerve conduction to neurology residents during their four-month rotation through the service in their first year. One of the busiest clinics is dedicated to the use of botulinum toxin injections as a treatment for focal dystonia, hemifacial spasm, spasticity, and migraine.
Dr. Sheean also provides formal teaching through tutorials and case presentations in the Clinical Core Clerkship course, and an annual lecture and demonstration on nerve conduction and EMG in the Basic Neurology course. He was honored with the Clinical Teaching Award for 1999 – 2000.
Dr. Sheean has published several papers on upper motor neurone syndrome and spasticity. He has served as Principal Investigator of three multicenter national clinical trials, and as Co-Investigator of two large trials evaluating treatment for the relief of neuropathic pain associated with HIV-1.
In addition, Dr. Sheean serves on numerous international advisory boards on spasticity management. Key memberships include the American Academy of Electrodiagnostic Medicine, Royal Australasian College of Physicians, Association of British Neurologists, and Myasthenia Gravis Foundation of California.
He has offered many CME day seminars across the country on the management of botulinum treatment of spasticity for the Institute of Continuing Medical Education. He is a frequent invited speaker at both the national and international levels. In 2001, he was invited by the Therapeutics Subcommittee of the American Academy of Neurology to organize a workshop on the treatment of spasticity with botox.